These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 24211137)

  • 21. Structure-based design of pseudopeptidic inhibitors for SIRT1 and SIRT2.
    Huhtiniemi T; Salo HS; Suuronen T; Poso A; Salminen A; Leppänen J; Jarho E; Lahtela-Kakkonen M
    J Med Chem; 2011 Oct; 54(19):6456-68. PubMed ID: 21895016
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Virtual screening approach of sirtuin inhibitors results in two new scaffolds.
    Kokkonen P; Kokkola T; Suuronen T; Poso A; Jarho E; Lahtela-Kakkonen M
    Eur J Pharm Sci; 2015 Aug; 76():27-32. PubMed ID: 25936698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural analysis of the inhibitory effects of polyphenols, (+)-hopeaphenol and (-)-isohopeaphenol, on human SIRT1.
    Loisruangsin A; Hikita K; Seto N; Niwa M; Takaya Y; Kaneda N
    Biofactors; 2019 Mar; 45(2):253-258. PubMed ID: 30537158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of novel SIRT3 inhibitor scaffolds by virtual screening.
    Salo HS; Laitinen T; Poso A; Jarho E; Lahtela-Kakkonen M
    Bioorg Med Chem Lett; 2013 May; 23(10):2990-5. PubMed ID: 23562596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, synthesis and structure-activity relationship studies of novel sirtuin 2 (SIRT2) inhibitors with a benzamide skeleton.
    Sakai T; Matsumoto Y; Ishikawa M; Sugita K; Hashimoto Y; Wakai N; Kitao A; Morishita E; Toyoshima C; Hayashi T; Akiyama T
    Bioorg Med Chem; 2015 Jan; 23(2):328-39. PubMed ID: 25515955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resveratrol with antioxidant activity inhibits matrix metalloproteinase via modulation of SIRT1 in human fibrosarcoma cells.
    Lee SJ; Kim MM
    Life Sci; 2011 Mar; 88(11-12):465-72. PubMed ID: 21238464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dual role of Zn2+ in maintaining structural integrity and suppressing deacetylase activity of SIRT1.
    Chen L; Feng Y; Zhou Y; Zhu W; Shen X; Chen K; Jiang H; Liu D
    J Inorg Biochem; 2010 Feb; 104(2):180-5. PubMed ID: 19923004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sirtuin 1-dependent resveratrol cytotoxicity and pro-differentiation activity on breast cancer cells.
    Deus CM; Serafim TL; Magalhães-Novais S; Vilaça A; Moreira AC; Sardão VA; Cardoso SM; Oliveira PJ
    Arch Toxicol; 2017 Mar; 91(3):1261-1278. PubMed ID: 27358235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resveratrol is neuroprotective because it is not a direct activator of Sirt1-A hypothesis.
    Tang BL
    Brain Res Bull; 2010 Mar; 81(4-5):359-61. PubMed ID: 20026255
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resveratrol and related compounds as antioxidants with an allosteric mechanism of action in epigenetic drug targets.
    Farghali H; Kutinová Canová N; Lekić N
    Physiol Res; 2013; 62(1):1-13. PubMed ID: 23173686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Substrate-specific activation of sirtuins by resveratrol.
    Kaeberlein M; McDonagh T; Heltweg B; Hixon J; Westman EA; Caldwell SD; Napper A; Curtis R; DiStefano PS; Fields S; Bedalov A; Kennedy BK
    J Biol Chem; 2005 Apr; 280(17):17038-45. PubMed ID: 15684413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery and characterization of small molecule SIRT3-specific inhibitors as revealed by mass spectrometry.
    Loharch S; Chhabra S; Kumar A; Swarup S; Parkesh R
    Bioorg Chem; 2021 May; 110():104768. PubMed ID: 33676042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SIRT1, a longevity gene, downregulates angiotensin II type 1 receptor expression in vascular smooth muscle cells.
    Miyazaki R; Ichiki T; Hashimoto T; Inanaga K; Imayama I; Sadoshima J; Sunagawa K
    Arterioscler Thromb Vasc Biol; 2008 Jul; 28(7):1263-9. PubMed ID: 18420994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of a sirtuin 3 inhibitor that displays selectivity over sirtuin 1 and 2.
    Galli U; Mesenzani O; Coppo C; Sorba G; Canonico PL; Tron GC; Genazzani AA
    Eur J Med Chem; 2012 Sep; 55():58-66. PubMed ID: 22835719
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resveratrol--a boon for treating Alzheimer's disease?
    Anekonda TS
    Brain Res Rev; 2006 Sep; 52(2):316-26. PubMed ID: 16766037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Crystal structures of SIRT3 reveal that the α2-α3 loop and α3-helix affect the interaction with long-chain acyl lysine.
    Gai W; Li H; Jiang H; Long Y; Liu D
    FEBS Lett; 2016 Sep; 590(17):3019-28. PubMed ID: 27501476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resveratrol inhibits proliferation and promotes apoptosis of osteosarcoma cells.
    Li Y; Bäckesjö CM; Haldosén LA; Lindgren U
    Eur J Pharmacol; 2009 May; 609(1-3):13-8. PubMed ID: 19285066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of SIRT3 by resveratrol ameliorates cardiac fibrosis and improves cardiac function via the TGF-β/Smad3 pathway.
    Chen T; Li J; Liu J; Li N; Wang S; Liu H; Zeng M; Zhang Y; Bu P
    Am J Physiol Heart Circ Physiol; 2015 Mar; 308(5):H424-34. PubMed ID: 25527776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Moderate calorie restriction attenuates age‑associated alterations and improves cardiac function by increasing SIRT1 and SIRT3 expression.
    Yu W; Qin J; Chen C; Fu Y; Wang W
    Mol Med Rep; 2018 Oct; 18(4):4087-4094. PubMed ID: 30132522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sirtuin 1 regulates skeletal myoblast survival and enhances differentiation in the presence of resveratrol.
    Saini A; Al-Shanti N; Sharples AP; Stewart CE
    Exp Physiol; 2012 Mar; 97(3):400-18. PubMed ID: 22125309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.